|
Re: AEGIS-II trial
|
6
|
Resverlogix Corp.
|
Mar 22, 2018 12:35PM
|
|
Re: RSU's awarded
|
6
|
Resverlogix Corp.
|
Sep 19, 2019 08:25PM
|
|
Re: A couple of recent RVX-208 articles related to selective bromodomain inhibition
|
6
|
Resverlogix Corp.
|
Sep 13, 2017 08:29PM
|
|
Re: More than "Material"
|
6
|
Resverlogix Corp.
|
Mar 16, 2021 01:25AM
|
|
Re: Dialysis patients and RVX-208
|
6
|
Resverlogix Corp.
|
Mar 13, 2019 10:31AM
|
|
Re: Naz listing?
|
6
|
Resverlogix Corp.
|
Apr 19, 2019 01:51PM
|
|
Re: BMO Current Value at 0
|
6
|
Zenith Epigenetics
|
Oct 31, 2018 12:12PM
|
|
Re: Alkaline Phosphatase and Alzheimer's Disease
|
6
|
Resverlogix Corp.
|
Jun 16, 2018 01:01AM
|
|
Re: 3rd Quarter Financial Statements
|
6
|
Resverlogix Corp.
|
Mar 15, 2017 03:58PM
|
|
Re: Bankruptcy?
|
6
|
Resverlogix Corp.
|
Dec 20, 2023 12:48PM
|
|
Re: Options Exercised
|
6
|
Resverlogix Corp.
|
Jul 08, 2018 08:58PM
|
|
Re: Extended Betonmace trial
|
6
|
Resverlogix Corp.
|
Apr 20, 2017 11:23PM
|
|
Re: NAFLD
|
6
|
Resverlogix Corp.
|
May 26, 2021 11:37PM
|
|
Re: What's the deal with Zenith?
|
6
|
Zenith Epigenetics
|
Jun 22, 2023 02:26PM
|
|
Re: Boy oh boy....
|
6
|
Resverlogix Corp.
|
Mar 09, 2020 07:05PM
|
|
Random thoughts - missed presentations/confer...
|
6
|
Resverlogix Corp.
|
Sep 18, 2017 12:35PM
|
|
Re: Resverlogix Reports Filing of New Intellectual Property on Key Renal Protection and Glucose Control Markers
|
6
|
Resverlogix Corp.
|
Nov 02, 2020 06:41PM
|
|
Re: Buyout?..
|
6
|
Resverlogix Corp.
|
Jun 02, 2019 08:32PM
|
|
Re: When to expect the 250th Event
|
6
|
Resverlogix Corp.
|
Feb 26, 2019 04:05PM
|
|
Today's wrap...my view
|
6
|
Resverlogix Corp.
|
Jun 12, 2019 06:07PM
|
